Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction

Girerd, N. et al. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9(4), pp. 2063-2069. (doi: 10.1002/ehf2.13929) (PMID:35429120) (PMCID:PMC9288781)

Abstract

No abstract available.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Pellicori, Dr Pierpaolo
• Authors: Girerd, N., Von Hunolstein, J.-J., Pellicori, P., Bayés-Genís, A., Jaarsma, T., Lund, L. H., Bilbault, P., Boivin, J.-M., Chouihed, T., Costa, J., Eicher, J.-C., Fall, E., Kenizou, D., Maillier, B., Nazeyrollas, P., Roul, G., Zannad, N., Rossignol, P., and Seronde, M.-F.
• College/School: College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre
• Journal Name: ESC Heart Failure
• Publisher: Wiley
• ISSN: 2055-5822
• ISSN (Online): 2055-5822
• Published Online: 15 April 2022
• Copyright Holders: Copyright © 2022 The Authors
• First Published: First published in ESC Heart Failure 9(4): 2063-2069
• Publisher Policy: Reproduced under a Creative Commons License